126 related articles for article (PubMed ID: 30497868)
21. Performance of fracture risk assessment tool in HIV-positive male individuals aged ≥45 years on suppressive antiretroviral therapy.
Tsai MS; Zhang JY; Sun HY; Liu WC; Wu PY; Yang CJ; Hung CC
J Int AIDS Soc; 2019 Aug; 22(8):e25383. PubMed ID: 31423752
[TBL] [Abstract][Full Text] [Related]
22. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.
Yu R; Leung J; Woo J
J Am Med Dir Assoc; 2014 Dec; 15(12):918-23. PubMed ID: 25262197
[TBL] [Abstract][Full Text] [Related]
23. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Schousboe JT; Ensrud KE; Johansson H; McCloskey EV; Kanis JA
Osteoporos Int; 2018 Mar; 29(3):759-767. PubMed ID: 29404625
[TBL] [Abstract][Full Text] [Related]
24. A comparison of three different guidelines for osteoporosis treatment in patients with rheumatoid arthritis in Korea.
Yoon J; Kwon SR; Lim MJ; Joo K; Moon CG; Jang J; Park W
Korean J Intern Med; 2010 Dec; 25(4):436-46. PubMed ID: 21179283
[TBL] [Abstract][Full Text] [Related]
25. Combining Computed Tomography-Based Bone Density Assessment with FRAX Screening in Men with Prostate Cancer.
McDonald AM; Jones JA; Cardan RA; Saag KS; Mayhew DL; Fiveash JB
J Clin Densitom; 2016 Oct; 19(4):430-435. PubMed ID: 27241940
[TBL] [Abstract][Full Text] [Related]
26. FRAX 10-year fracture risk in rheumatoid arthritis assessed with and without bone mineral density - are we treating our patients under bDMARDs?
Seabra Rato M; Oliveira Pinheiro F; Garcia S; Fernandes B; Bernardo A; Gaio R; Costa L; Bernardes M
ARP Rheumatol; 2023; 2(1):47-52. PubMed ID: 36739534
[TBL] [Abstract][Full Text] [Related]
27. The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis.
Phuan-Udom R; Lektrakul N; Katchamart W
Clin Rheumatol; 2018 Oct; 37(10):2603-2610. PubMed ID: 30039267
[TBL] [Abstract][Full Text] [Related]
28. Automated DXA-based finite element analysis for hip fracture risk stratification: a cross-sectional study.
Yang S; Leslie WD; Luo Y; Goertzen AL; Ahmed S; Ward LM; Delubac I; Lix LM
Osteoporos Int; 2018 Jan; 29(1):191-200. PubMed ID: 29038836
[TBL] [Abstract][Full Text] [Related]
29. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
Donaldson MG; Palermo L; Ensrud KE; Hochberg MC; Schousboe JT; Cummings SR
J Bone Miner Res; 2012 Aug; 27(8):1804-10. PubMed ID: 22492479
[TBL] [Abstract][Full Text] [Related]
30. Association between trabecular bone score and risk factors for fractures in Korean female patients with rheumatoid arthritis.
Kim D; Cho SK; Kim JY; Choi YY; Sung YK
Mod Rheumatol; 2016 Jul; 26(4):540-5. PubMed ID: 26418481
[TBL] [Abstract][Full Text] [Related]
31. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA
Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil.
Silva DMW; Borba VZC; Kanis JA
Arch Osteoporos; 2017 Dec; 12(1):111. PubMed ID: 29224172
[TBL] [Abstract][Full Text] [Related]
33. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
Lippuner K
Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
[TBL] [Abstract][Full Text] [Related]
34. FRAX calculated without BMD does not correctly identify Caucasian men with densitometric evidence of osteoporosis.
Hamdy RC; Seier E; Whalen K; Clark WA; Hicks K; Piggee TB
Osteoporos Int; 2018 Apr; 29(4):947-952. PubMed ID: 29397409
[TBL] [Abstract][Full Text] [Related]
35. [Comparison fracture risk calculated by FRAX tool].
Carranza-Lira S; Lanuza-López MC; Sandoval-Barragán MP
Ginecol Obstet Mex; 2014 Sep; 82(9):591-4. PubMed ID: 25412552
[TBL] [Abstract][Full Text] [Related]
36. Is It Possible to Increase the Clinical Effectiveness of the Fracture Risk Assessment Tool in Osteopenia Patients by Taking Into Account Bone Mineral Density Values?
Park JS; Lee J; Park YS
J Clin Densitom; 2016; 19(3):340-5. PubMed ID: 26822485
[TBL] [Abstract][Full Text] [Related]
37. Fracture risk assessment and osteoporosis treatment disparities in 3,970 Japanese patients with rheumatoid arthritis.
Furuya T; Hosoi T; Saito S; Inoue E; Taniguchi A; Momohara S; Yamanaka H
Clin Rheumatol; 2011 Aug; 30(8):1105-11. PubMed ID: 21484222
[TBL] [Abstract][Full Text] [Related]
38. Digital X-ray radiogrammetry in the study of osteoporotic fractures: Comparison to dual energy X-ray absorptiometry and FRAX.
Kälvesten J; Lui LY; Brismar T; Cummings S
Bone; 2016 May; 86():30-5. PubMed ID: 26921822
[TBL] [Abstract][Full Text] [Related]
39. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
40. The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study.
Esmaeilzadeh S; Cesme F; Oral A; Yaliman A; Sindel D
Endocr Res; 2016 Aug; 41(3):248-60. PubMed ID: 26864472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
